Biosimulation Market By Offering (Software {Physiologically Based Pharmacokinetic, Quantitative Systems Pharmacology, PK & PD Models, Systems Biology & Disease Progression Models, AI-based Tools}, Services {Model Development & Validation, Data Analysis & Interpretation, Virtual Clinical Trial Design, Regulatory Consulting & Submissions, Training & Technical Support}), By Modeling Approach (Mechanistic Models, Population-based Models, Data-driven Models, Engineering Models), By Therapeutic Area (Oncology, Neurology & CNS Disorders, Cardiovascular Diseases, Metabolic & Endocrine Disorders, Respiratory Disorders, Immunology & Autoimmune Diseases, Others), By Deployment Mode (On-premise Solutions, Cloud-based, Hybrid Models), By Application (Drug Discovery & Development, Preclinical Testing & Toxicology Studies, Clinical Trial Optimization, Dose Selection & Regimen Optimization, Safety & Risk Assessment, Regulatory Approval & Label Expansion, Others), By End User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROs), Academic & Research Institutes, Regulatory Authorities, Others), Global Market Size, Segmental Analysis, Regional Overview, Company Share Analysis, Leading Company Profiles And Market Forecast, 2025 – 2035.

---

Report Coverage:

By Offering

• Software
  • Physiologically Based Pharmacokinetic
  • Quantitative Systems Pharmacology
  • PK & PD Models
  • Systems Biology & Disease Progression Models
  • AI-based Tools
• Services
  • Model Development & Validation
  • Data Analysis & Interpretation
  • Virtual Clinical Trial Design
  • Regulatory Consulting & Submissions
  • Training & Technical Support

By Modeling Approach

• Mechanistic Models
• Population-based Models
• Data-driven Models
• Engineering Models

By Therapeutic Area

• Oncology
• Neurology & CNS Disorders
• Cardiovascular Diseases
• Metabolic & Endocrine Disorders
• Respiratory Disorders
• Immunology & Autoimmune Diseases
• Others

By Deployment Mode

• On-premise Solutions
• Cloud-based
• Hybrid Models

By Application

• Drug Discovery & Development
• Preclinical Testing & Toxicology Studies
• Clinical Trial Optimization
• Dose Selection & Regimen Optimization
• Safety & Risk Assessment
• Regulatory Approval & Label Expansion
• Others

By End User

• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations (CROs)
• Academic & Research Institutes
• Regulatory Authorities
• Others

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of the Middle East & Africa

List of Companies:

• Certara, L.P.
• Dassault Systèmes SE
• Simulations Plus, Inc.
• Schrödinger, Inc.
• Genedata AG
• Chemical Computing Group ULC (CCG)
• Physiomics Plc
• In Silico Biosciences, Inc.
• Applied BioMath, LLC
• VeriSIM Life, Inc.
• Medidata Solutions, Inc.
• BIOVIA
• Entelos, Inc.
• Arzeda Corporation
• Simulations Plus GmbH